- World rank, all time
- #28,862 of 42,892
- Rank in Brazil
- #490 of 870
- Research works
- 148 ▲ 129% vs 2013–17
- Citations
- 3.6k 24.4 per fractional work
- Top-10% rate
- 3.8% record average 16.5%
- Open access
- 56% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.7×. Every wedge is a field page.
- Immunology and Microbiology 3.7×
- Medicine 3.1×
- Economics, Econometrics and Finance 3.1×
- Health Professions 2.5×
- Pharmacology, Toxicology and Pharmaceutics 2.3×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Earth and Planetary Sciences 0.6×
- Social Sciences 0.5×
- Chemistry 0.5×
- Agricultural and Biological Sciences 0.5×
- Decision Sciences 0.5×
- Nursing 0.5×
- Business, Management and Accounting 0.4×
- Mathematics 0.3×
- Environmental Science 0.3×
- Engineering 0.2×
- Arts and Humanities 0.1×
- Neuroscience 0.1×
- Psychology 0.1×
- Computer Science 0.0×
Who are the top researchers at GlaxoSmithKline (Brazil)?
Ranked on the composite score, Gabriela de Azevedo Abreu lead among researchers whose main affiliation is GlaxoSmithKline (Brazil).
- 1 Gabriela de Azevedo Abreu Brazil · #798,897 worldwide 39 citations · 17 works
Which keywords describe research at GlaxoSmithKline (Brazil)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Cervical Cancer, Clinical Trials, Breast Cancer, Chemotherapy, Ovarian Cancer and Metastasis.
- Proteasome Inhibitors
- Respiratory
- HIV Transmission
- Pathogenesis
- Global Burden
- Vaccine
- Chronic Rhinosinusitis
- Endometrial Carcinoma
- Brachytherapy
- Survival Analysis
- JAK2 Mutation
- Tumor Models
- Genomic Analysis
- Mutation Analysis
- Cytoreductive Surgery
- Metastasis
- Biomarkers
- Chemotherapy
- Clinical Trials
- Quality of Life
- Epidemiology
- Cervical Cancer
- Breast Cancer
- Public Health
- Clinical Practice Guidelines
- Ovarian Cancer
- Mastectomy
- Papanicolaou Test
- Inflammation
- Economic Growth
- Myelofibrosis
- Antiretroviral Therapy
- Diagnosis
- Treatment
- Nasal Polyps
- Ageing Population
- Health Care Expenditure
- Viral Load
- Preexposure Prophylaxis
- Drug Resistance
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology7▲ 3.9×31 topics
- Quality of Life5▲ 7.6×5 topics
- Cervical Cancer4▲ 89×3 topics
- Clinical Trials4▲ 12×4 topics
- Breast Cancer3▲ 30×3 topics
- Chemotherapy3▲ 9.9×4 topics
- Public Health3▲ 4.2×10 topics
- Biomarkers3▲ 8.2×3 topics
- Clinical Practice Guidelines3▲ 10×2 topics
- Metastasis3▲ 16×4 topics
- Ovarian Cancer3▲ 64×2 topics
- Cytoreductive Surgery3▲ 84×2 topics
- Mastectomy2▲ 311×1 topic
- Mutation Analysis2▲ 71×2 topics
- Papanicolaou Test2▲ 311×1 topic
- Genomic Analysis2▲ 21×1 topic
- Inflammation2▲ 2.4×9 topics
- Tumor Models2▲ 87×1 topic
- Economic Growth2▲ 5.7×4 topics
- JAK2 Mutation2▲ 199×1 topic
- Myelofibrosis2▲ 199×1 topic
- Survival Analysis2▲ 17×3 topics
- Antiretroviral Therapy2▲ 23×4 topics
- Brachytherapy2▲ 96×1 topic
- Diagnosis2▲ 4.1×7 topics
- Endometrial Carcinoma2▲ 96×1 topic
- Treatment2▲ 3.1×11 topics
- Chronic Rhinosinusitis2▲ 107×1 topic
- Nasal Polyps2▲ 107×1 topic
- Vaccine2▲ 8.0×5 topics
- Ageing Population1▲ 73×1 topic
- Global Burden1▲ 5.4×5 topics
- Health Care Expenditure1▲ 73×1 topic
- Pathogenesis1▲ 5.9×5 topics
- Viral Load1▲ 34×2 topics
- HIV Transmission1▲ 35×1 topic
- Preexposure Prophylaxis1▲ 53×1 topic
- Respiratory1▲ 26×2 topics
- Drug Resistance1▲ 8.4×5 topics
- Proteasome Inhibitors1▲ 33×2 topics
Which research topics does GlaxoSmithKline (Brazil) publish most on?
By volume in 2022–2025: Women's cancer prevention and management, Ovarian cancer diagnosis and treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment and Endometrial and Cervical Cancer Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Women's cancer prevention and management Public Health, Environmental and Occupational Health 2 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
- 3 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 2 works
- 4 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
- 5 Sinusitis and nasal conditions Otorhinolaryngology 2 works
- 6 Global Health Care Issues General Health Professions 1 works
- 7 HIV/AIDS Research and Interventions Infectious Diseases 1 works
- 8 Multiple Myeloma Research and Treatments Hematology 1 works
- 9 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (Brazil)'s research output changed?
Output in 2018–2022 was 129% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rio de Janeiro
- Universidade Federal do Rio de Janeiro
- Universidade do Estado do Rio de Janeiro
- Fundação Oswaldo Cruz
- Pontifícia Universidade Católica do Rio de Janeiro
- Universidade Federal do Estado do Rio de Janeiro
- Fundação Getulio Vargas
- Petrobras (Brazil)
- State University of Norte Fluminense
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.